Evaluation of a Rapid Topiramate Titration Scheme for the Early Detection of Cognitive Side Effects.
Juri-Alexander WittGuido WidmanNiels HansenRandi von WredeChristian E ElgerChristoph HelmstaedterPublished in: CNS drugs (2022)
Physicians might be able to detect adverse cognitive side effects sooner in epilepsy patients if TPM is administered using a faster titration rate while applying repeated cognitive assessments within days. This approach might help prevent any unnoticed intolerance and eventual negative consequences for the patient. Therefore, we recommend monitoring early on for adverse changes instead of withholding a potentially effective treatment option because of anticipated side effects.